Dimensional Fund Advisors Portfolio holdings
Dimensional Fund Advisors (DFA), founded in 1981 by David Booth and Rex Sinquefield and headquartered in Austin, Texas, is an investment management firm renowned for its evidence-based, low-cost approach to investing, grounded in academic research from Nobel laureates like Eugene Fama and Kenneth French. Managing hundreds of billions in assets, DFA focuses on systematic, passive strategies that tilt toward factors like small-cap, value, and profitability stocks, primarily through mutual funds and institutional portfolios rather than retail brokerage services. The firm’s philosophy eschews market timing and stock picking, instead emphasizing diversification and efficient market exposure, often requiring investors to access its funds through approved financial advisors. With a global presence and a reputation for disciplined, data-driven investing, DFA has carved a unique niche in the industry, blending academic rigor with practical application.
Top Buys
| 1 |
Dimensional Emerging Markets Core Equity 2 ETF
DFEM
|
+$941M |
| 2 |
Dimensional Emerging Markets Value ETF
DFEV
|
+$933M |
| 3 |
Dimensional Emerging Markets High Profitability ETF
DEHP
|
+$467M |
| 4 |
Exxon Mobil
XOM
|
+$386M |
| 5 |
Warner Bros
WBD
|
+$260M |
Top Sells
| 1 |
Dimensional National Municipal Bond ETF
DFNM
|
+$654M |
| 2 |
AT&T
T
|
+$372M |
| 3 |
Amazon
AMZN
|
+$350M |
| 4 |
Dimensional US High Profitability ETF
DUHP
|
+$263M |
| 5 |
CERN
Cerner Corp
CERN
|
+$212M |
Sector Composition
| 1 | Financials | 16.93% |
| 2 | Technology | 15.17% |
| 3 | Industrials | 11.99% |
| 4 | Healthcare | 11.63% |
| 5 | Consumer Discretionary | 9.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3101
Ryan Specialty Holdings
RYAN
$6.53B
| $417K | ﹤0.01% |
10,647
+853
| +9% | +$33.4K |
|
3102
HF Foods Group
HFFG
$171M
| $416K | ﹤0.01% |
79,766
+38,419
| +93% | +$200K |
|
|
VXRT
3103
DELISTED
Vaxart
VXRT
| $416K | ﹤0.01% |
119,079
| – | – |
|
3104
Ring Energy
REI
$215M
| $415K | ﹤0.01% |
156,044
+43,049
| +38% | +$114K |
|
3105
Live Ventures
LIVE
$54.1M
| $414K | ﹤0.01% |
16,549
+8,651
| +110% | +$216K |
|
3106
Q32 Bio
QTTB
$21.7M
| $408K | ﹤0.01% |
11,518
-6,729
| -37% | -$238K |
|
|
NSTG
3107
DELISTED
NanoString Technologies, Inc.
NSTG
| $408K | ﹤0.01% |
32,141
-6,414
| -17% | -$81.4K |
|
3108
Cytosorbents Corp
CTSO
$59.3M
| $407K | ﹤0.01% |
185,629
-59,311
| -24% | -$130K |
|
3109
Bank7 Corp
BSVN
$460M
| $405K | ﹤0.01% |
17,720
+4,275
| +32% | +$97.7K |
|
3110
Global E Online
GLBE
$6.22B
| $402K | ﹤0.01% |
19,907
-448
| -2% | -$9.05K |
|
|
CFRX
3111
DELISTED
ContraFect Corporation
CFRX
| $402K | ﹤0.01% |
1,639
+229
| +16% | +$56.2K |
|
|
TOUR
3112
Tuniu
TOUR
$109M
| $399K | ﹤0.01% |
381,528
| – | – |
|
3113
Doximity
DOCS
$12.9B
| $398K | ﹤0.01% |
11,443
+492
| +4% | +$17.1K |
|
|
KNTE
3114
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
| $396K | ﹤0.01% |
+31,393
| New | +$396K |
|
3115
Trio-Tech International
TRT
$22.8M
| $395K | ﹤0.01% |
91,195
+1,277
| +1% | +$5.53K |
|
3116
Exagen
XGN
$212M
| $395K | ﹤0.01% |
68,813
-3,238
| -4% | -$18.6K |
|
3117
Design Therapeutics
DSGN
$349M
| $394K | ﹤0.01% |
+28,144
| New | +$394K |
|
|
ZEPP
3118
Zepp Health
ZEPP
$744M
| $392K | ﹤0.01% |
52,920
+5,476
| +12% | +$40.6K |
|
3119
Adverum Biotechnologies
ADVM
$69.5M
| $387K | ﹤0.01% |
32,315
-27,047
| -46% | -$324K |
|
|
GRTS
3120
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
| $387K | ﹤0.01% |
159,800
-20,002
| -11% | -$48.4K |
|
3121
monday.com
MNDY
$9.66B
| $386K | ﹤0.01% |
3,745
+14
| +0.4% | +$1.44K |
|
|
FFBW
3122
DELISTED
FFBW, Inc. Common Stock
FFBW
| $386K | ﹤0.01% |
31,797
+4,781
| +18% | +$58K |
|
|
NEWR
3123
DELISTED
New Relic, Inc.
NEWR
| $385K | ﹤0.01% |
7,702
-236,949
| -97% | -$11.8M |
|
|
TCRR
3124
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
| $381K | ﹤0.01% |
131,393
+7,442
| +6% | +$21.6K |
|
3125
Everspin Technologies
MRAM
$154M
| $380K | ﹤0.01% |
72,556
+24,861
| +52% | +$130K |
|